Quetiapine

May 14, 2020

Luye Pharma Grants Exclusive Promotion Rights to Moksha8, Deepening Strategic Presence in Latin America for CNS Business

Feb 10, 2020

Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel® and Seroquel XR® in South Africa and Certain Neighbouring Countries

May 30, 2019

Luye Pharma's Rykindo® NDA Filing Accepted by the U.S. FDA

Mar 28, 2019

Luye Pharma's Rykindo® Expected to Be the First Chinese Innovative Drug to Receive U.S. FDA Approval

Sep 05, 2018

Global Bipolar Disorder Disease Market 2018-2024 - Otsuka initiates Phase III Development of Rexulti for Bipolar Mania Without Proof-of-Concept Trial

Jul 22, 2018

Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China

Jun 25, 2018

Top 50 In Global Pharma By 2025 -- Luye Pharma Group Announces "Whole Value Chain" Global Collaboration Strategy

Jun 06, 2018

Seroquel Stepping Stone: How Luye Will Use Seroquel to Expand in Emerging Markets

May 27, 2018

Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR

May 23, 2018

Drug Overview & Outlook for Seroquel/Seroquel XR (AstraZeneca, Kyowa Pharmaceutical) 2017-2018 to 2026 with Key Pivotal Trial Data